Spyre Therapeutics (SYRE) R&D In Process (2023)
Historic R&D In Process for Spyre Therapeutics (SYRE) over the last 1 years, with Q3 2023 value amounting to -$298000.0.
- Spyre Therapeutics' R&D In Process changed N/A to -$298000.0 in Q3 2023 from the same period last year, while for Sep 2024 it was -$298000.0, marking a year-over-year decrease of 10022.89%. This contributed to the annual value of $130.2 million for FY2023, which is N/A changed from last year.
- As of Q3 2023, Spyre Therapeutics' R&D In Process stood at -$298000.0.
- Spyre Therapeutics' R&D In Process' 5-year high stood at $130.5 million during Q2 2023, with a 5-year trough of -$298000.0 in Q3 2023.